Blood disorders arise from a surprisingly wide range of causes, from inherited gene mutations to simple nutritional gaps to medications you might already be taking. Globally, anemia alone affects an estimated half a billion women of reproductive age and 269 million young children, making blood disorders among the most common health problems worldwide. Understanding the underlying cause matters because it determines whether a blood disorder is preventable, treatable, or something you need to manage long-term.
Inherited Gene Mutations
Many blood disorders run in families because they’re caused by mutations passed from parent to child. Sickle cell disease results from a single amino acid change in the hemoglobin protein, causing red blood cells to warp into a rigid crescent shape that clogs small blood vessels. Thalassemia, another inherited hemoglobin disorder, involves more than 200 known mutations that reduce the body’s ability to produce normal hemoglobin chains. Both conditions follow a recessive inheritance pattern, meaning you typically need to inherit a copy of the mutated gene from each parent to develop the full disease.
Hemophilia, the classic bleeding disorder, stems from mutations in genes that produce clotting factors. Because those genes sit on the X chromosome, hemophilia overwhelmingly affects males, while females usually carry the trait without symptoms. Fanconi anemia is rarer but more severe: mutations in DNA repair genes cause chromosomes to break during cell division, leading to progressive bone marrow failure and a heightened risk of leukemia, often before age 40.
Another inherited condition, dyskeratosis congenita, involves defective maintenance of telomeres (the protective caps on chromosomes). When telomeres shorten too quickly, blood-forming stem cells in the bone marrow burn out prematurely. In fact, shortened telomeres show up in roughly half of all patients with aplastic anemia, whether inherited or not.
Nutritional Deficiencies
Iron deficiency is the single most common cause of anemia worldwide. Without enough iron, the body produces smaller-than-normal red blood cells that can’t carry oxygen efficiently. This type, called microcytic anemia, is especially prevalent in young children and women with heavy menstrual periods.
Vitamin B12 deficiency is the leading cause of megaloblastic anemia, a condition where red blood cells grow abnormally large and can’t function properly. Severe B12 deficiency can drop hemoglobin levels dangerously low, sometimes below 4 grams per deciliter (normal is roughly 12 to 17, depending on sex). It can also suppress production of white blood cells and platelets simultaneously, mimicking more serious bone marrow diseases. Folate deficiency causes a similar type of large-cell anemia, though it has become less common since many countries began fortifying grain products with folic acid to prevent birth defects.
Copper deficiency is an underrecognized cause of blood abnormalities. Low copper levels can produce anemia and dangerously low white blood cell counts, a combination that closely mimics myelodysplastic syndrome, a pre-cancerous bone marrow condition. Excessive zinc supplementation is one common trigger for copper depletion, since zinc and copper compete for absorption in the gut.
Autoimmune Destruction of Blood Cells
Sometimes the immune system mistakes healthy blood cells for threats and produces antibodies against them. In autoimmune hemolytic anemia, antibodies latch onto red blood cells, tagging them for destruction by immune cells called macrophages, primarily in the spleen and liver. The process involves a double hit: the antibodies themselves mark the cells, and a complement system (part of the body’s immune defense) amplifies the signal. Neither low-level antibodies nor low-level complement alone is enough to trigger significant destruction, but together they make the removal highly efficient.
Immune thrombocytopenic purpura, or ITP, follows the same basic mechanism but targets platelets instead. Antibodies coat platelets, and macrophages in the spleen rapidly consume them, causing platelet counts to plummet. The result is easy bruising, tiny red spots on the skin, and in severe cases, dangerous bleeding. Both conditions frequently appear alongside other autoimmune diseases like lupus, or alongside certain cancers of the immune system.
Bone Marrow Failure
All blood cells are manufactured in the bone marrow, so damage to this factory affects every cell type at once. Aplastic anemia, the most recognized form of marrow failure, can be inherited or acquired. Acquired aplastic anemia is most often triggered by an overactive immune response where the body’s own immune cells attack marrow stem cells. Drugs, chemical exposures, radiation, and viral infections can all set off this process, though in many cases no specific trigger is ever identified.
Myelodysplastic syndromes represent a different kind of marrow dysfunction where stem cells produce blood cells that are abnormal in shape and function. About one-third of people with myelodysplastic syndromes eventually develop leukemia, making these conditions both a blood disorder in their own right and a precursor to cancer.
Medications and Environmental Toxins
A long list of medications can suppress blood cell production as a side effect. Drug classes most commonly linked to acquired aplastic anemia include certain anti-seizure medications, anti-inflammatory drugs (NSAIDs), drugs used to treat overactive thyroid, and some antibiotics. Chemotherapy agents, particularly alkylating agents, are well-known causes of both marrow suppression and secondary blood cancers. The risk rises with higher total doses and longer treatment durations.
Some drugs interfere with DNA synthesis directly, producing megaloblastic anemia that looks identical to B12 or folate deficiency under a microscope. Certain antiviral medications used to treat HIV fall into this category.
Among environmental exposures, benzene is the most thoroughly documented blood toxin. Chronic benzene exposure, which can occur in petroleum refining, rubber manufacturing, and cigarette smoking, damages bone marrow stem cells and raises the risk of aplastic anemia and leukemia. Radiation exposure, whether from medical treatment or environmental sources, kills rapidly dividing marrow cells and can cause long-lasting blood count abnormalities.
Infections That Disrupt Blood Counts
Several infections directly attack or suppress blood cell production. HIV progressively destroys a specific type of white blood cell, but it also causes anemia and low platelet counts as the disease advances. Hepatitis B and C viruses can trigger aplastic anemia by provoking an immune attack against the bone marrow. Epstein-Barr virus, the cause of mononucleosis, temporarily drives white blood cell counts down in many people during active infection.
Malaria is one of the most significant infectious causes of anemia globally. The parasite invades red blood cells directly, reproducing inside them until the cells rupture. In regions where malaria is endemic, repeated infections contribute heavily to childhood anemia, compounding the effects of iron deficiency. Tuberculosis also suppresses white blood cell production and can cause anemia through chronic inflammation.
Clotting Disorders and Hypercoagulability
Not all blood disorders involve too few cells or abnormal cells. Some involve blood that clots too easily, raising the risk of deep vein thrombosis, pulmonary embolism, and stroke. The most common genetic cause is the Factor V Leiden mutation, which makes a key clotting protein resistant to being switched off. Genetic factors can be identified in up to 30% of people who develop blood clots, with Factor V Leiden and a second mutation called prothrombin G20210A accounting for most of those cases.
Deficiencies in natural anticoagulant proteins, specifically protein C and protein S, are rarer (affecting about 1% of the population) but carry a higher clotting risk per person. Protein C deficiency can cause blood clots as early as the teenage years. These deficiencies can be inherited, but they also develop from liver disease, kidney failure, or certain medications, meaning the same clotting disorder can have either a genetic or an acquired origin.
Blood Cancers
Leukemia, lymphoma, and multiple myeloma are cancers that originate in blood-forming cells or immune cells. Their causes overlap with many of the triggers already described. Smoking accounts for an estimated 20% of acute myeloid leukemia cases. Prior radiation therapy and chemotherapy for other cancers can cause DNA mutations that lead to leukemia years later, a well-documented risk for survivors of Hodgkin lymphoma, breast cancer, and ovarian cancer.
Genetics play a role here too. People with Down syndrome, Fanconi anemia, and several other inherited conditions face elevated leukemia risk. Family history matters for certain types: having a parent, sibling, or child with chronic lymphocytic leukemia increases your own risk two- to four-fold. And as noted, about a third of myelodysplastic syndrome cases progress to acute leukemia, making preexisting bone marrow disorders one of the clearest risk factors for blood cancer.
How Blood Disorders Are Detected
Most blood disorders first show up on a complete blood count, one of the most commonly ordered lab tests. The key numbers your doctor looks at include hemoglobin (normal range is 13.2 to 16.6 g/dL for males, 11.6 to 15 g/dL for females), white blood cell count (3.4 to 9.6 billion cells per liter), and platelet count (135 to 371 billion per liter, varying slightly by sex). Values outside these ranges don’t automatically mean a serious disorder, since temporary infections, medications, and even dehydration can shift results. But persistent abnormalities prompt further testing to identify which of these many causes is at work.
Because the causes range from something as simple as low iron intake to something as complex as a bone marrow cancer, the path from an abnormal blood count to a diagnosis can involve nutritional labs, genetic testing, antibody screens, or a bone marrow biopsy, depending on which direction the initial results point.